Hongfei Li

Hongfei Li is a seasoned biostatistician with extensive experience in the pharmaceutical and academic sectors. Currently serving as Senior Manager of Biostatistics at Revolution Medicines since September 2025, Hongfei Li previously held the position of Principal Biostatistician at Incyte from August 2022 to September 2025. Prior roles include Teaching and Research Assistant at UConn Statistics from May 2019 to August 2022, as well as a Biostatistics Intern at Bristol Myers Squibb in summer 2021. Notable achievements include developing innovative methodologies for incorporating real-world data in clinical trials and conducting comprehensive analyses to inform healthcare performance evaluations. Hongfei Li holds a PhD in Statistics from the University of Connecticut and a BS in Statistics from Nankai University.